Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Lundbeck acquires remaining rights to ischemic stroke treatment candidate

Feb. 29, 2012

Antisense Therapeutics to form joint venture for development of ATL-1102

Feb. 29, 2012

Selventa enters new collaboration

Feb. 29, 2012

Biodesix enters new collaboration

Feb. 28, 2012

Merck & Co. licenses Protein Sciences technology for vaccine research

Feb. 28, 2012

MorphoSys announces signing of protein engineering agreement

Feb. 28, 2012

Galen acquires chemotherapy agent from Gilead

Feb. 27, 2012

Angiochem and GSK launch new collaboration

Feb. 27, 2012

Auxilium grants Actelion exclusive rights to Xiaflex in certain territories

Feb. 23, 2012

Daiichi Sankyo and Terumo enter new vaccine collaboration

Feb. 23, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...